186 related articles for article (PubMed ID: 26980707)
21. [Mechanism concerning antitumor effect of oridonin on multiple myeloma cell line U266].
Duan HQ; Li MY; Gao L; Zhang JF; Wang W; Li Y; Ma YG; Wang CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):364-9. PubMed ID: 24763006
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
[TBL] [Abstract][Full Text] [Related]
23. Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
Yao Z; Xie F; Li M; Liang Z; Xu W; Yang J; Liu C; Li H; Zhou H; Qu LH
Cell Death Dis; 2017 Feb; 8(2):e2633. PubMed ID: 28230866
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of Oridonin injection on heterotransplanted gastric adenocarcinoma in nude mice and its mechanism].
Chen JH; Wang SB; Li EM; Chen LM; Yuan SJ; Wang RL; Shen ZY
Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):89-92. PubMed ID: 18646687
[TBL] [Abstract][Full Text] [Related]
25. Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway.
Liu H; Qian C; Shen Z
Tumour Biol; 2014 Sep; 35(9):9139-46. PubMed ID: 24916572
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of EGFR signaling augments oridonin-induced apoptosis in human laryngeal cancer cells via enhancing oxidative stress coincident with activation of both the intrinsic and extrinsic apoptotic pathways.
Kang N; Zhang JH; Qiu F; Tashiro S; Onodera S; Ikejima T
Cancer Lett; 2010 Aug; 294(2):147-58. PubMed ID: 20202741
[TBL] [Abstract][Full Text] [Related]
27. A novel combination of oridonin and valproic acid in enhancement of apoptosis induction of HL-60 leukemia cells.
Shi M; Ren X; Wang X; Wang H; Liu G; Yuan X; Zheng S; Yu L; Pan S; Song G; Guo Q; Li L; Zhang X; Zhang Z; Ding H; Jiang G
Int J Oncol; 2016 Feb; 48(2):734-46. PubMed ID: 26676928
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of oridonin on proliferation of RPMI8226 cells and the possible underlying mechanism.
Hao Y; Zhao F; Luo Y; Zhang M; Li S
J Tradit Chin Med; 2016 Apr; 36(2):225-30. PubMed ID: 27400478
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of caspase-9 by oridonin, a diterpenoid isolated from Rabdosia rubescens, augments apoptosis in human laryngeal cancer cells.
Kang N; Cao SJ; Zhou Y; He H; Tashiro S; Onodera S; Qiu F; Ikejima T
Int J Oncol; 2015 Dec; 47(6):2045-56. PubMed ID: 26648189
[TBL] [Abstract][Full Text] [Related]
30. Bcl-2 up-regulation and P-p53 down-regulation account for the low sensitivity of murine L929 fibrosarcoma cells to oridonin-induced apoptosis.
Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2005 Nov; 28(11):2068-74. PubMed ID: 16272691
[TBL] [Abstract][Full Text] [Related]
31. Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.
Ikezoe T; Chen SS; Tong XJ; Heber D; Taguchi H; Koeffler HP
Int J Oncol; 2003 Oct; 23(4):1187-93. PubMed ID: 12964003
[TBL] [Abstract][Full Text] [Related]
32. Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells.
Jin S; Shen JN; Wang J; Huang G; Zhou JG
Cancer Biol Ther; 2007 Feb; 6(2):261-8. PubMed ID: 17218775
[TBL] [Abstract][Full Text] [Related]
33. Characterisation of a Tip60 specific inhibitor, NU9056, in prostate cancer.
Coffey K; Blackburn TJ; Cook S; Golding BT; Griffin RJ; Hardcastle IR; Hewitt L; Huberman K; McNeill HV; Newell DR; Roche C; Ryan-Munden CA; Watson A; Robson CN
PLoS One; 2012; 7(10):e45539. PubMed ID: 23056207
[TBL] [Abstract][Full Text] [Related]
34. Oridonin inhibits mTOR signaling and the growth of lung cancer tumors.
Wang YY; Lv YF; Lu L; Cai L
Anticancer Drugs; 2014 Nov; 25(10):1192-200. PubMed ID: 25075795
[TBL] [Abstract][Full Text] [Related]
35. NF-kappab facilitates oridonin-induced apoptosis and autophagy in HT1080 cells through a p53-mediated pathway.
Zhang Y; Wu Y; Wu D; Tashiro S; Onodera S; Ikejima T
Arch Biochem Biophys; 2009 Sep; 489(1-2):25-33. PubMed ID: 19646415
[TBL] [Abstract][Full Text] [Related]
36. Oridonin induces apoptosis, inhibits migration and invasion on highly-metastatic human breast cancer cells.
Wang S; Zhong Z; Wan J; Tan W; Wu G; Chen M; Wang Y
Am J Chin Med; 2013; 41(1):177-96. PubMed ID: 23336515
[TBL] [Abstract][Full Text] [Related]
37. A Novel Potent Anticancer Compound Optimized from a Natural Oridonin Scaffold Induces Apoptosis and Cell Cycle Arrest through the Mitochondrial Pathway.
Xu S; Yao H; Luo S; Zhang YK; Yang DH; Li D; Wang G; Hu M; Qiu Y; Wu X; Yao H; Xie W; Chen ZS; Xu J
J Med Chem; 2017 Feb; 60(4):1449-1468. PubMed ID: 28165738
[TBL] [Abstract][Full Text] [Related]
38. Oridonin induces apoptosis of HeLa cells via altering expression of Bcl-2/Bax and activating caspase-3/ICAD pathway.
Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2004 May; 25(5):691-8. PubMed ID: 15132839
[TBL] [Abstract][Full Text] [Related]
39. Geridonin and paclitaxel act synergistically to inhibit the proliferation of gastric cancer cells through ROS-mediated regulation of the PTEN/PI3K/Akt pathway.
Wang SQ; Wang C; Chang LM; Zhou KR; Wang JW; Ke Y; Yang DX; Shi HG; Wang R; Shi XL; Ma LY; Liu HM
Oncotarget; 2016 Nov; 7(45):72990-73002. PubMed ID: 27659528
[TBL] [Abstract][Full Text] [Related]
40. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres.
Ji Q; Hao X; Meng Y; Zhang M; Desano J; Fan D; Xu L
BMC Cancer; 2008 Sep; 8():266. PubMed ID: 18803879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
